News and breakthroughs in tissue analysis, biomarkers, and pathology technology.
Flagship Recognized Among 10 Best Technology Solution Providers of 2018
October 31, 2018 – Flagship Biosciences is honored to be named by Industry Era Magazine as one of the 10 Best Technology Solution Providers of
Predicine and Flagship Biosciences Partner to Support Global Biomarker Development
Predicine and Flagship Biosciences are excited to announce a strategic venture to provide complimentary and comprehensive biomarker profiling to empower clinical trials in the immuno-oncology (IO) space.
Flagship Receives Global Technology Innovation Award
Frost & Sullivan News Release: Flagship Biosciences Recognized by Frost & Sullivan for Its Industry-leading AI-powered cTA® Platform for Predictive Diagnostics Santa Clara, CA, September
Flagship’s Digital Tissue Image Analysis Approach Validated in Assessment of Dystrophin Muscle Biopsies; Findings Published in Archives of Pathology & Laboratory Medicine
Westminster, CO, September 6, 2018 – Flagship Biosciences’ MuscleMap algorithm that supports therapeutic development for DMD, a fatal neuromuscular disease, has been validated to be
Flagship Secures Series A Funding to Accelerate Growth in Drug Development and Diagnostics Services
Westminster, CO, July 10, 2018 – Flagship Biosciences has closed a series A round of funding to advance the growth of its computational tissue image
Flagship publishes article on using IHC and digital imaging to improve patient selection for PD-L1 therapy
First NSCLC study using cTA to report IHC data in immuno-oncology Westminster, CO, June 7, 2018 – Flagship is proud to co-author the research paper,
